Sharp Healthcare v. Leavitt

555 F. Supp. 2d 1121, 2008 U.S. Dist. LEXIS 28282, 2008 WL 927891
CourtDistrict Court, S.D. California
DecidedApril 4, 2008
Docket3:08-mj-00170
StatusPublished
Cited by2 cases

This text of 555 F. Supp. 2d 1121 (Sharp Healthcare v. Leavitt) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sharp Healthcare v. Leavitt, 555 F. Supp. 2d 1121, 2008 U.S. Dist. LEXIS 28282, 2008 WL 927891 (S.D. Cal. 2008).

Opinion

ORDER FINDING THE COURT HAS JURISDICTION AND PLAINTIFFS’ CLAIMS ARE RIPE FOR REVIEW

THOMAS J. WHELAN, District Judge.

Plaintiffs Sharp Healthcare, Scripps Health, and Internist Laboratory filed a motion for a temporary restraining order. In denying the motion, the Court ordered Plaintiffs to show cause why this case should not be dismissed for lack of jurisdiction and standing. Having reviewed the parties’ responses to the OSC, the Court finds that jurisdiction and standing exist.

I. Procedural Background

On February 4, 2008, Plaintiffs filed a motion for a TRO to enjoin the Secretary’s deadline to submit bids to provide clinical diagnostic laboratory tests covered by Medicare Part B. On February 14, 2008, the Court denied the TRO finding that the Secretary had raised serious issues regarding the Court’s jurisdiction (thereby preventing Plaintiffs from establishing a likelihood of success on the merits) and finding that Plaintiffs would not suffer irreparable harm by having to comply with the application deadline.

In light of the serious jurisdictional issues raised by the Secretary, the Court also issued an OSC requiring the parties to provide briefing on the following issues:

(1) Do Plaintiffs have to exhaust administrative remedies before pursuing their claims in federal court?
(2) Is judicial review of Plaintiffs’ claims barred under 42 U.S.C. § 1395w-3 (10)?
(3) Are ripeness and standing requirements met?

*1123 The parties have submitted their briefing. For the reasons discussed below, the Court finds that it has jurisdiction, and that Plaintiffs have standing.

II. Exhaustion of Administrative Remedies

In Shalala v. Illinois Council on Long Term Care, Inc., 529 U.S. 1, 120 S.Ct. 1084, 146 L.Ed.2d 1 (2000), the Supreme Court held that 42 U.S.C. § 405(h), which is incorporated into the Medicare Act by 42 U.S.C. § 1395Ü, “demands the ‘channeling’ of virtually all legal attacks through the agency.” Id. at 13, 120 S.Ct. 1084. In so holding, however, the Supreme Court recognized an exception to the channeling requirement where application of § 405(h) would amount to “no review at all.” Id. at 19, 120 S.Ct. 1084.

There is no dispute that Plaintiffs did not pursue administrative remedies before filing this lawsuit. The issue, therefore, is whether requiring Plaintiffs to first seek administrative review would amount to “no review at all.”

The Secretary argues that administrative review is available for Plaintiffs’ claims. According to the Secretary, after winners are selected, Plaintiffs — whether they win or lose — will be in a position to submit claims for laboratory tests to Medicare and, if not satisfied with the reimbursement, may pursue administrative claims.

But the controlling statute provides that losing laboratories are not entitled to payment from Medicare. See 42 U.S.C. § 1395w-3(b)(5)(A) (“Payment under this part for competitively priced items and services ... shall be based on bids submitted and accepted under this section....”) And the Department of Health and Human Services’ October 17, 2007 Notice specifically states that “[w]e will not directly pay ... for services furnished by a required bidder that ... did not win.” 72 F.R. 58856-01; see also Def.’s Opp. to TRO, p. 5 (“Required bidders who either lose in the bidding process or fail to submit bids may not bill Medicare directly for any of the laboratory tests involved in the project.”) Accordingly, contrary to the Secretary’s contention, if Plaintiffs lose, they cannot submit claims to Medicare and, therefore, will not be in a position to obtain administrative review. 1

Furthermore, in a February 1, 2008 letter sent to providers, the Secretary stated that non-winning laboratories cannot pursue administrative appeals. (See Pits.’ OSC Brief, Ex. A, p. 7 (“non-winner laboratories ... have no appeal rights when Medicare denies payment for the test....”).) This statement contradicts the Secretary’s representation to the Court that administrative review is available to Plaintiffs.

The Secretary attempts to explain away this contradiction on two grounds. First, the Secretary asserts, in essence, that the position in the February letter could change to allow for administrative review in the future. But the Court must rule based on the present set of facts. And at present, non-winning laboratories have no appeal rights.

The Secretary next argues that the February letter reflects his interpretation that 42 U.S.C. § 1395w-3(b)(10) bars both judicial and administrative review of all of Plaintiffs’ claims. Far from helping the Secretary, this argument seals his fate. *1124 Based on the Secretary’s interpretation of subsection (b)(10), there is no dispute that Plaintiffs could not have obtained administrative review before filing this lawsuit. Nor could Plaintiffs have obtained review if they waited until after winning bids were selected. Accordingly, the Court must find that application of § 405(h)’s administrative channeling requirement would amount to no review at all. Plaintiffs, therefore, were not required to pursue administrative remedies before filing this lawsuit.

III. Availability of Judicial Review

The statute authorizing the demonstration project, 42 U.S.C. § 1395w-3(e), includes a limitation on judicial review. Subsection (b)(10) prohibits judicial review of the following six areas related to the project:

(A) the establishment of payment amounts under paragraph (5);
(B) the awarding of contracts under this section;
(C) the designation of competitive acquisition areas under subsection (a)(1)(A) of this section;
(D) the phased-in implementation under subsection (a)(1)(B) of this section;
(E) the selection of items and services for competitive acquisition under subsection (a)(2) of this section; or
(F) the bidding structure and number of contractors selected under this section.

In opposing the TRO, the Secretary argued that (b)(10) precludes judicial review of all of Plaintiffs’ claims.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Key Medical Supply, Inc. v. Kathleen Sebelius
764 F.3d 955 (Eighth Circuit, 2014)
Texas Alliance for Home Care Services v. Sebelius
811 F. Supp. 2d 76 (District of Columbia, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
555 F. Supp. 2d 1121, 2008 U.S. Dist. LEXIS 28282, 2008 WL 927891, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sharp-healthcare-v-leavitt-casd-2008.